Subscribe To
Anavex Life Sciences to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, today announced that Christopher U. Missling, PhD, President […] The post Anavex Life Sciences to Present at the H...
Read More
Posted: Apr 25 2023, 11:30
Author Name: forextv
Views: 110765